Park Place Capital’s Bristol-Myers Squibb BMY Stock Holding History

Park Place Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.55M	Buy	61,611 +57,682	+1,468%	+$3.31M	0.56%	38
2026 Q1	$238K	Buy	3,929 +2,579	+191%	+$150K	0.05%	180
2025 Q4	$72.8K	Buy	1,350 +11	+0.8%	+$529	0.02%	278
2025 Q3	$60.4K	Sell	1,339 -181	-12%	-$8.45K	0.01%	300
2025 Q2	$72.2K	Sell	1,520 -9,852	-87%	-$484K	0.02%	295
2025 Q1	$694K	Sell	11,372 -1,391	-11%	-$81.1K	0.19%	93
2024 Q4	$722K	Sell	12,763 -599	-4%	-$33.5K	0.2%	101
2024 Q3	$691K	Buy	13,362 +4,509	+51%	+$212K	0.2%	105
2024 Q2	$368K	Buy	8,853 +114	+1%	+$5.1K	0.12%	157
2024 Q1	$474K	Buy	8,739 +5,083	+139%	+$259K	0.17%	139
2023 Q4	$188K	Sell	3,656 -1,767	-33%	-$92.8K	0.07%	230
2023 Q3	$315K	Sell	5,423 -1,900	-26%	-$116K	0.09%	181
2023 Q2	$468K	Buy	7,323 +1,587	+28%	+$106K	0.13%	151
2023 Q1	$398K	Buy	5,736 +526	+10%	+$37.1K	0.11%	170
2022 Q4	$375K	Buy	+5,210	New	+$393K	0.11%	173

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Park Place Capital's BMY Position: Q2 2026 in Review

Park Place Capital increased its Bristol-Myers Squibb (BMY) stake by 1,468% in Q2 2026, buying an estimated $3.31M and bringing the position to 61,611 shares worth $3.55M. The position accounts for 0.56% of the portfolio, ranked #38.

Park Place Capital first reported a position in BMY in Q4 2022 and has held it in 15 quarters since. 2,526 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Park Place Capital held 61,611 shares of Bristol-Myers Squibb worth $3.55M as of Q2 2026.
Park Place Capital bought 57,682 Bristol-Myers Squibb shares in Q2 2026, an estimated $3.31M.
Bristol-Myers Squibb made up 0.56% of Park Place Capital's portfolio in Q2 2026, its #38 holding.
Park Place Capital first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 15 quarters since.
2,526 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.